Chemoinformaics analysis of MASLINIC-ACID-METHYL-ESTER
| Molecular Weight | 486.737 | nRot | 1 |
| Heavy Atom Molecular Weight | 436.337 | nRig | 27 |
| Exact Molecular Weight | 486.371 | nRing | 5 |
| Solubility: LogS | -5.133 | nHRing | 0 |
| Solubility: LogP | 6.117 | No. of Aliphatic Rings | 5 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 5 |
| Atoms Count | 85 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 35 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 4 |
| No. of Hydrogen atom | 50 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 31 | No. of Saturated Rings | 4 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 88.3176 |
| nHD | 2 | BPOL | 52.7644 |
| QED | 0.337 |
| Synth | 4.801 |
| Natural Product Likeliness | 3.209 |
| NR-PPAR-gamma | 0.437 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.735 |
| Pgp-sub | 0 |
| HIA | 0.025 |
| CACO-2 | -4.995 |
| MDCK | 0.0000146 |
| BBB | 0.663 |
| PPB | 0.978877 |
| VDSS | 1.3 |
| FU | 0.0404134 |
| CYP1A2-inh | 0.007 |
| CYP1A2-sub | 0.416 |
| CYP2c19-inh | 0.043 |
| CYP2c19-sub | 0.95 |
| CYP2c9-inh | 0.138 |
| CYP2c9-sub | 0.456 |
| CYP2d6-inh | 0.036 |
| CYP2d6-sub | 0.706 |
| CYP3a4-inh | 0.34 |
| CYP3a4-sub | 0.514 |
| CL | 14.278 |
| T12 | 0.013 |
| hERG | 0.004 |
| Ames | 0.041 |
| ROA | 0.176 |
| SkinSen | 0.009 |
| Carcinogencity | 0.034 |
| EI | 0.019 |
| Respiratory | 0.957 |
| NR-Aromatase | 0.703 |
| Antiviral | No |
| Prediction | 0.597839 |